MENU
+Compare
CHE
Stock ticker: NYSE
AS OF
Jun 4, 11:57 AM (EDT)
Price
$563.72
Change
-$4.67 (-0.82%)
Capitalization
9.7B

CHE stock forecast, quote, news & analysis

Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value... Show more

CHE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for CHE with price predictions
Jun 03, 2025

CHE saw its Stochastic Oscillator peaks and leaves the overbought zone

The Stochastic Oscillator for CHE moved out of overbought territory on May 30, 2025. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 69 similar instances where the indicator exited the overbought zone. In of the 69 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 02, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CHE as a result. In of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CHE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CHE entered a downward trend on May 05, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for CHE just turned positive on May 16, 2025. Looking at past instances where CHE's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CHE advanced for three days, in of 326 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock slightly better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CHE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.741) is normal, around the industry mean (4.650). P/E Ratio (35.730) is within average values for comparable stocks, (71.885). CHE's Projected Growth (PEG Ratio) (2.721) is slightly higher than the industry average of (1.595). CHE has a moderately low Dividend Yield (0.002) as compared to the industry average of (0.025). P/S Ratio (4.301) is also within normal values, averaging (9.268).

A.I.Advisor
published Dividends

CHE is expected to pay dividends on June 17, 2025

Chemed Corp CHE Stock Dividends
A dividend of $0.50 per share will be paid with a record date of June 17, 2025, and an ex-dividend date of May 29, 2025. The last dividend of $0.50 was paid on March 14. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are DaVita (NYSE:DVA), Community Health Systems (NYSE:CYH).

Industry description

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

Market Cap

The average market capitalization across the Medical/Nursing Services Industry is 4.28B. The market cap for tickers in the group ranges from 1.86K to 88.21B. HCA holds the highest valuation in this group at 88.21B. The lowest valued company is CSAY at 1.86K.

High and low price notable news

The average weekly price growth across all stocks in the Medical/Nursing Services Industry was 3%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was 12%. MODV experienced the highest price growth at 106%, while KJFI experienced the biggest fall at -26%.

Volume

The average weekly volume growth across all stocks in the Medical/Nursing Services Industry was 56%. For the same stocks of the Industry, the average monthly volume growth was 36% and the average quarterly volume growth was 48%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 61
Price Growth Rating: 57
SMR Rating: 77
Profit Risk Rating: 79
Seasonality Score: 5 (-100 ... +100)
View a ticker or compare two or three
CHE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a holding medical company

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Or Nursing Services
Address
255 East Fifth Street
Phone
+1 513 762-6690
Employees
15087
Web
https://www.chemed.com